Associations between vitamin D receptor gene polymorphisms and ankylosing spondylitis in Chinese Han population: a case–control study

[1]  K. Tizaoui,et al.  Association between VDR polymorphisms and rheumatoid arthritis disease: Systematic review and updated meta-analysis of case-control studies. , 2015, Immunobiology.

[2]  A. Berraies,et al.  Association of Vitamin D Receptor Gene Polymorphisms with Asthma Risk: Systematic Review and Updated Meta-analysis of Case–Control Studies , 2014, Lung.

[3]  D. M. van der Heijde,et al.  Optimisation of rheumatology assessments - the actual situation in axial spondyloarthritis including ankylosing spondylitis. , 2014, Clinical and experimental rheumatology.

[4]  J. Nowak,et al.  The Role of Toll‐Like Receptors and Vitamin D in Diabetes Mellitus Type 1 – A Review , 2014, Scandinavian journal of immunology.

[5]  Weiya Zhang,et al.  Associations between vitamin D receptor gene polymorphisms and osteoarthritis: an updated meta-analysis. , 2014, Rheumatology.

[6]  R. Inman,et al.  The Application of Clinical Genetics Dovepress the Genetic Basis of Ankylosing Spondylitis: New Insights into Disease Pathogenesis , 2022 .

[7]  D. Bikle,et al.  Vitamin D metabolism, mechanism of action, and clinical applications. , 2014, Chemistry & biology.

[8]  R. Colbert,et al.  Review: The Interleukin‐23/Interleukin‐17 Axis in Spondyloarthritis Pathogenesis: Th17 and Beyond , 2014, Arthritis & rheumatology.

[9]  Yu-qin Pan,et al.  Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk , 2014, Tumor Biology.

[10]  Qiao Liu,et al.  Vitamin D Receptor Gene Polymorphisms on the Risk of Tuberculosis, a Meta-Analysis of 29 Case-Control Studies , 2013, PloS one.

[11]  Ashima,et al.  Study of bone mineral density in patients with ankylosing spondylitis. , 2013, Journal of clinical and diagnostic research : JCDR.

[12]  M. Dougados,et al.  Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis. , 2013, Arthritis and rheumatism.

[13]  D. Deb,et al.  Vitamin D receptor signaling in podocytes protects against diabetic nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.

[14]  K. Siminovitch,et al.  Vitamin D Receptor Polymorphism rs2228570 (Fok1) Is Associated with Rheumatoid Arthritis in North American Natives , 2012, The Journal of Rheumatology.

[15]  Seyed Morteza Taghavi,et al.  Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population , 2012, Molecular Biology Reports.

[16]  Xuejun Zeng,et al.  Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population , 2012, Lupus.

[17]  Jing Wu,et al.  A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis , 2011, Nature Genetics.

[18]  Dan-Yu Lin,et al.  A general framework for detecting disease associations with rare variants in sequencing studies. , 2011, American journal of human genetics.

[19]  Paul Weston,et al.  Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility , 2011, Nature Genetics.

[20]  M. Dougados,et al.  Spondyloarthritis , 2011, The Lancet.

[21]  Michael M. Ward,et al.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci , 2010, Nature Genetics.

[22]  D. Kamen,et al.  Vitamin D in systemic lupus erythematosus , 2008, Current opinion in rheumatology.

[23]  Simon C. Potter,et al.  Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants , 2007, Nature Genetics.

[24]  M. Cutolo,et al.  Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. , 2006, Clinical and experimental rheumatology.

[25]  Ahmed Rebai,et al.  Association study of VDR gene with rheumatoid arthritis in the French population , 2005, Genes and Immunity.

[26]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[27]  A. Uitterlinden,et al.  Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.

[28]  G. Tauber,et al.  Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis , 2003, Osteoporosis International.

[29]  M. Galligan,et al.  Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene , 2001, Molecular and Cellular Endocrinology.

[30]  G. Coetzee,et al.  Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability. , 1999, Biochimica et biophysica acta.

[31]  J. Eisman,et al.  Prediction of bone density from vitamin D receptor alleles , 1994, Nature.

[32]  S. Manolagas,et al.  Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. , 1989, The Journal of clinical endocrinology and metabolism.

[33]  M. Fanger,et al.  Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. , 1987, The Journal of clinical investigation.

[34]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[35]  Jian-hua Xu,et al.  Vitamin D in ankylosing spondylitis: review and meta-analysis. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[36]  R. Díaz-Peña,et al.  [Genetics of ankylosing spondylitis]. , 2014, Revista medica de Chile.

[37]  M. Dougados,et al.  Arthritis 2 Spondyloarthritis , 2011 .

[38]  M. Cippitelli,et al.  Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. , 1998, The Journal of clinical investigation.